Loading data
RCUSNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 33 m USD | 51 m USD | 37 m USD | 38 m USD | 383 m USD |
| Research and development expense | 523 m USD | 448 m USD | 340 m USD | 288 m USD | 257 m USD |
| Operating profit | -386 m USD | -330 m USD | -340 m USD | -280 m USD | 54 m USD |
| Profit before tax | -353 m USD | -282 m USD | -301 m USD | -266 m USD | 55 m USD |
| Income tax expense | 0 USD | 1 m USD | 6 m USD | 1 m USD | 2 m USD |
| Net income (reported basis) | -353 m USD | -283 m USD | -307 m USD | -267 m USD | 53 m USD |
| Basic earnings per share | -3.29 USD/share | -3.14 USD/share | -4.15 USD/share | -3.71 USD/share | 0.76 USD/share |
| Diluted earnings per share | -3.29 USD/share | -3.14 USD/share | -4.15 USD/share | -3.71 USD/share | 0.71 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.